Procter & Gamble (PG)CEO sold ~$491K

~$491K

Approx. value · 3,227 sh @ $152.23

62K

Holds after · shares reported

Traded

Oct 2, 2025

Filed

Oct 6, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 26, 2024CongressDisclosed purchase of PG — reported range $1,001 - $15,000
2. Oct 29, 2024CongressDisclosed purchase of PG — reported range $1,001 - $15,000
3. Jun 24, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
4. Jul 2, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
5. Jul 10, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
6. Jul 11, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
7. Aug 7, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
8. Aug 8, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
9. Aug 13, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
10. Aug 14, 2025CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
11. Aug 19, 2025Insider · 9 peopleInsiders: 9 sales (~$15.6M)
12. Aug 21, 2025Insider · 3 peopleInsiders: 4 sales (~$4.9M)
13. Aug 29, 2025InsiderOfficer sold ~$157K of PG shares in the open market
14. Sep 8, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 10.0%
15. Sep 10, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
16. Sep 17, 2025Congress · 1 personMembers of Congress: 2 sales
17. Sep 22, 2025Congress · 1 personMembers of Congress: 2 purchases
18. Sep 23, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
19. Oct 2, 2025 · this disclosureInsiderCEO sold ~$491K of PG shares in the open market

What came next

1. Oct 2, 2025Insider · 7 peopleInsiders: 8 sales (~$4.4M)
2. Oct 16, 2025Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“At the Annual Meeting of Shareholders of The Procter & Gamble Company (the "Company”), held on October 14, 2025, the Company’s shareholders approved The Procter & Gamble 2025 Stock and Incentive Compensation Plan (the “2025 Stock Plan”).”
3. Oct 16, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
4. Oct 17, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
5. Oct 24, 2025Company filing · Form 8-K · ResultsReported its results
6. Oct 30, 2025InsiderOfficer sold ~$108K of PG shares in the open market
7. Nov 5, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
8. Nov 6, 2025CongressDisclosed purchase of PG — reported range $15,001 - $50,000
9. Nov 10, 2025InsiderCFO sold ~$190 of PG shares in the open market
10. Nov 13, 2025CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
11. Nov 18, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
12. Dec 1, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
13. Dec 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Jennifer Davis, currently Chief Executive Officer - Health Care, notified the Company of her intent to retire effective June 30, 2026, after more than 33 years of service.”
14. Dec 18, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
15. Dec 24, 2025CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
16. Jan 9, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
17. Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
18. Jan 23, 2026InsiderOfficer sold ~$14.5M of PG shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Procter & Gamble

For Procter & Gamble, OQRO holds 21 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports and 117 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PG page.

Other recent filings by Jennifer L. Davis, CEO - Health Care

• SEC Form 4 at Procter & Gamble (PG)Aug 21, 2025
• SEC Form 4 at Procter & Gamble (PG)Apr 30, 2025
• SEC Form 4 at Procter & Gamble (PG)Oct 3, 2024

The full history of Jennifer L. Davis, CEO - Health Care is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Procter & Gamble

• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 144Oct 1, 2026
• SEC Form 144Oct 1, 2026
• SEC Form 144Oct 1, 2026

Everything OQRO holds on this company is on its PG page.